European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: Practical guidance for use in patients at very high cardiovascular risk

  1. Landmesser, U.
  2. Chapman, M.J.
  3. Farnier, M.
  4. Gencer, B.
  5. Gielen, S.
  6. Hovingh, G.K.
  7. Lüscher, T.F.
  8. Sinning, D.
  9. Tokgözoǧlu, L.
  10. Wiklund, O.
  11. Zamorano, J.L.
  12. Pinto, F.J.
  13. Catapano, A.L.
Revue:
European Heart Journal

ISSN: 1522-9645,  0195-668X

Année de publication: 2017

Volumen: 38

Número: 29

Pages: 2245-2255

Type: Article

DOI: 10.1093/EURHEARTJ/EHW480 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus